Preclinical investigation of an innovative magnesium-based bone graft substitute for potential orthopaedic applications  by Liu, Chen et al.
Journal of Orthopaedic Translation (2014) 2, 139e148Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /ees.elsevier .com/jotORIGINAL ARTICLEPreclinical investigation of an innovative
magnesium-based bone graft substitute
for potential orthopaedic applications
Chen Liu a,b,1, Peng Wan b,*,1, Li Li Tan b, Kehong Wang a,
Ke Yang ba Department of Materials Science and Engineering, Nanjing University of Science and Technology,
Nanjing 210094, China
b Institute of Metal Research, Chinese Academy of Science, Shenyang 110016, ChinaReceived 4 May 2014; received in revised form 31 May 2014; accepted 3 June 2014
Available online 23 June 2014KEYWORDS
Bone graft
substitutes;
Degradation;
Mechanical property;
Mg alloys;
Strontium* Corresponding author. Institute of
E-mail address: pwan@imr.ac.cn (
1 These two authors contributed equ
http://dx.doi.org/10.1016/j.jot.2014.
2214-031X/Copyright ª 2014, The Aut
license (http://creativecommons.org/Summary Degradable or corrosive biometal is an attractive research and development (R&D)
area in clinical orthopaedics. This study was designed to investigate biomechanical and biolog-
ical properties of magnesium (Mg) and strontium (Sr) with a focus on Mg-based
metals, including pure Mg and Mgexwt% Sr (x Z 0.25, x Z 1.0, x Z 1.5, x Z 2.5) alloys, as
potential bone graft substitutes in respect to their mechanical strength, corrosion resistance,
and cytocompatibility for further optimization and establishing indications for relevant
in vivo applications. Our data showed that the tensile and compressive strength increased with
addition of Sr because of the Mg17Sr2 precipitation strengthen. Compared with commercially
used bone graft substitutes, the mechanical properties of MgeSr alloys were close to those
of cortical bone, and the compressive strength could reach 300 MPa, suggesting its potential
application for load-bearing bone as bone defect filler. The corrosion rates of Mgexwt% Sr al-
loys were controlled in the range of 0.05e0.07 mm/y, indicating feasibility of bone grafting
and the in situ bone repair process. Moreover, MgeSr alloys also exhibit good cytocompatibility
and antibacterial properties. Our innovation presented in this work supported in vivo clinical
indication-based assessment of biodegradable Mg-based metals that could be potential candi-
dates for bone graft substitutes for future orthopaedic applications.
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Table 1 Chemical composition of the MgeSr alloys (wt%).
Nominal
composition
Mge0.5Sr Mge1.5Sr Mge2.5Sr Mge4.0Sr
Actual Sr
contents (wt%)
0.25 1.0 1.5 2.5
Mg Z magnesium; Sr Z strontium.
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The healing of bone fractures is a physiological process that
results in bone union [1]. However, significant bone defects
caused by a high-energy traumatic event or large bone
resection may require bone grafting in order to fill the de-
fects and provide support for biological repair of the defect.
Bone grafting is a common surgical procedure, performed in
approximately 10% of all skeletal reconstructive surgery
cases [2]. It has been estimated that 2.2 million grafting
procedures are performed worldwide each year [3,4].
The bone graft substitutes are characterized as a spectrum
of products that have various effects on bone healing. The
perfect bone substitute should be osteoconductive, osteoin-
ductive, osteogenetic without risk of transferring infectious
diseases, readily available, manageable, biocompatible, and
bioresorbable [5]. Moreover, from amechanical point of view,
bone substitutes should have mechanical strength similar to
that of the bone for replacement.
The gold standard for restoring bone defects has long
been considered to be autologous bone grafting. However,
donor-site complications have been shown to occur, clinical
benefits are not guaranteed, and there is a high rate of
associated complications [6]. Large amounts of alternative
bone-graft substitutes are currently commercially available
for orthopaedic use. Main products are made with calcium
phosphate ceramics [hydroxyapatite (HA) and tricalcium
phosphate (TCP)], calcium sulfate (CaSO4), bioactive
glasses, and biological/synthetic composites. They vary in
composition, mechanical action, and special characteris-
tics. The disadvantages encountered with those materials
in clinical settings include low and unpredictable resorp-
tion, poor mechanical properties, and limited ability of
osteoinduction [7,8].
Magnesium (Mg) and its alloys are promising novel metals
as orthopaedic implants because of their satisfactory me-
chanical properties, attractive biological performance as
well as their biodegradability in vivo [9]. In addition, the
stress shielding effect might be avoided because the moduli
of Mg and its alloys are closer to those of cortical bones
[10]. Currently, the vascular stents and orthopaedic im-
plants are two dominant medical applications for biode-
gradable Mg-based alloys. The advancement in tailoring
controlled degradation rate, excellent mechanical prop-
erty, and osteopromotion [11] inspire the development of
the Mg alloys as potential bone graft substitutes.
Strontium (Sr) has been recently reported for its use in
medical applications [12]. Sr is a component of human
bones, and its role in bone is known to promote the growth
of osteoblasts and prevent bone resorption [13]. Brar et al.
[14] studied Mgexwt% Sr (xZ 0.5, xZ 1.0, xZ 1.5) alloys
and found the lowest biodegradation rate in the Mge0.5Sr
alloy. Gu et al. [12] reported the MgeSr binary alloys with
1e4 wt% Sr and proved as-rolled Mge2Sr alloy possessed the
best combination of corrosion resistance, high strength,
and in vivo biocompatibility.
As previously mentioned, pure Mg and MgeSr alloys were
found to have combining properties of degradability,
excellent mechanical properties, and biocompatibility,
which may meet the clinical requirement for potential
application for bone defect repair. Thus, in this work, theperformance of pure Mg and MgeSr alloys with wt% Sr
varying between 0.25 and 2.5 were studied as alternatives
for bone substitutes. The mechanical and degradation
properties of Mg-based metals were also compared with
commercial products such as CaSO4, HA, and b-TCP as
positive controls. Such design would provide a solid basis
for its translation toward further research and development
(R&D) in establishing clinical indications for our Mg-based
scaffold materials.
Materials and methods
Materials preparation
In the current study, pure Mg (99.9%) and MgeSr alloys were
studied as the potential Mg-based bone graft substitutes.
The binary Mgexwt% Sr (xZ 0.25, xZ 1.0, xZ 1.5, xZ 2.5)
alloys were fabricated using pure Mg (99.9%) and a Mge30wt
% Sr master alloy in a high-purity graphite crucible under the
protection of a mixed gas atmosphere of SF6 (1 vol%) and
carbon dioxide (CO2), (balance). The melting was held at
730C for 30 minutes and stirred with a graphite rod. The
melt was then poured into a steel mold preheated to 300C.
The binary MgeSr alloys were encapsulated in quartz tubes
under vacuum for homogenization treatments at 500C for
20 hours and quenched in water. The as-cast ingots were hot
extruded into bars with extrusion ratio of 64:1 at 390C. The
as-extruded pure Mg was prepared following the aforemen-
tioned procedure. The samples were cut into pieces with
dimensions of V10  2 mm3 for microstructure character-
ization, corrosion experiments, and cytotoxicity tests. All
samples were grounded with SiC paper up to 2000 grit, fol-
lowed by ultrasonic cleaning in acetone, absolute ethanol,
and distilled water for 10 minutes each and then sterilization
with ethylene oxide. To compare the performances of bone
substitutes, the CaSO4 (Osteoset, Wright Medical Technol-
ogy), HA (Pro-Osteon, Biomet Osteobiologics), and b-TCP
(ChronOS, Synthes) were studied as the controls in this work.
Compositional analysis and microstructural
characterization
The chemical compositions of the alloys measured by
inductively coupled plasma atomic emission spectrometry
(ICP-OES, Optima 7300DV, PerkinElmer, MA, USA) are listed
in Table 1. The nominal composition of strontium content
was designed in a range of 0.5e4.0 wt%; however, because
of the high burning loss rate of Sr during the melting pro-
cess, the actual composition was 0.25, 1.0, 1.5, and 2.5wt%
Sr. The samples (V10  2 mm3) for microstructural char-
acterization were etched using acetic picral solution. The
microstructure of the prepared samples was investigated
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performed using an X-ray diffractometer (Rigaku D/Max
2500PC, Tokyo, Japan) with Cu-Ka radiation to identify the
crystal structure of the phases. The XRD pattern was made
with MDI Jade 5.0 software (Materials Data Inc., CA,USA).
Mechanical testing
Tensile testing was used to determine the yield strength (YS)
and ultimate tensile strength (UTS) of the alloy samples. The
tensile tests were performed at ambient temperature with a
displacement rate of 0.12 mm/minutes according to Amer-
ican Society for Testing and Materials (ASTM) E8-04 [15]. The
compressive strength of the prepared cylinders immersed
for different time periods (0 days, 7 days, 14 days, 28 days)
was measured by a universal testing machine (Instron-1195,
Instron, Norwood, MA, USA) at a loading rate of 0.5 mm/
minutes. Beam-shaped samples with dimensions of
3 5 30 mm3 were prepared for three-point bending tests
in accordance with ASTM E290-13 [16]. Three parallel
specimens were taken for each group.
Electrochemical tests
The electrochemical corrosion behaviour was investigated
by potentiodynamic polarization and electrochemical
impedance spectroscopy using an electrochemical work-
station (Verserstat3, Princeton Applied Research, TN, USA)
controlled by VersaStudio software. The simulated body
fluid was the Hank Balanced Salt Solution (HBSS 10-527,
Lonza Walkersville, MD, USA). A three-electrode cell
featuring a platinum counter electrode and a saturated
calomel reference electrode (SCE) was used. The samples
were allowed to stabilize at their open circuit potential
(OCP) for 30 minutes before the measurements were star-
ted. Potentiodynamic polarization tests were conducted at
a sweep rate of 0.5 mV/s within a scan range of0.25 V with
reference to OCP. All electrochemical tests were conducted
in triplicate to ensure the reproducibility of results.
Immersion tests
The samples were immersed in the Hank’s solution (HBSS
10e527) at 37.5  0.5 C for 4 weeks. The ratio of surface
area/solution volume was 1.25 cm2/mL. The pH value of
the solution was measured during the immersion test. The
measurements were taken at 24-hour intervals. The weight
loss was measured after 28 days to calculate the corrosion
rate according to ASTM G31-72 [17]. Corrosion products
were cleaned using chromic acid solution [200 g/L chro-
mium trioxide (CrO3) and 10 g/L silver nitrate (AgNO3)] for
15 minutes in an ultrasonic bath at room temperature until
all signs of corrosion products and coating were removed.
Biocompatibility evaluation
Cell culture
Murine calvarial preosteoblasts MC3T3-E1 were purchased
from ATCC (NO.CRL-12424 MD, USA) and cultured in modified
Eagle medium alpha (a-MEM) and 10% fetal bovine serum
(FBS) in a humidified atmosphere of 5% CO2 at 37
C. Themedium was replaced at regular intervals. The cytocompat-
ibility of the experimental material was evaluated by both
indirect and direct contacts. The control groups involved the
use of a-MEM medium with 10% FBS. For the indirect contact
test, extracts were prepared using a-MEM medium with 10%
FBS as the extraction medium with the surface area of
extraction medium ratio 1.25 cm2/mL at 37C for 24 hours.
The supernatant fluid was withdrawn for the extracts prep-
aration. Osteogenic differentiation of preosteoblasts MC3T3-
E1was induced by osteogenic medium (culturing medium
supplemented with 10 mM Naeb-glycerophosphate, 10.8 M
dexamethasone, and 50 mg/mL ascorbic acid). The direct
assay was used in the cell adhesion and morphology obser-
vation. Samples were settled at the bottom of each well of
48-well plates and 500-mL cell suspensions were seeded in
each well at a density of 3  104 cells/mL.
Cytotoxicity assay
A 100-mL cell suspension was seeded onto 96-well plates at a
density of 2  104 cells/mL and then cultured in a-MEM with
10% FBS. The cultures were incubated in a 37C, 5% CO2
environment for 24 hours. Then, 3-4,5-dimethyl-2-thia-
zolyl)-2,5-diphenyl-2-H-tetrazolium bromide MTT was
diluted with the modified Eagle medium (1:9 ratio by vol-
ume) and then added to each plate with 100 mL per well. The
samples were incubated with MTT for 4 hours at 37C, and
then 150 mL dimethylsulfoxide was added in each well. The
well plate was then shaken well and the optical density (OD)
values of all wells were analysed by a microplate reader at a
wavelength of 490 nm with a reference wavelength of
570 nm. All cell experiments were conducted in triplicate. A
cell viability ratio (CVR) for every sample was calculated to
evaluate the cytotoxicity using the equation: CVRZ (viable
cell count in experimental extract)/(viable cell count in
control extract) according to ISO10993-5 [18].
Cell adhesion experiment
Cells incubated at 2 104 cells/100mLmodified a-MEMwere
seeded on the substrates and allowed to attach for 30 mi-
nutes, 60 minutes, and 120 minutes. At each prescribed time
point, the nonadherent cells were removed by rinsing with
PBS solution. Cells were fixed and stained with 40, 60-
diamidino-2-phenylindole (DAPI) for 30 minutes at 37C.
The cell numbers in five random fields were counted under a
fluorescence microscope (Olympus B  51, Tokyo, Japan).
Antibacterial performance
The pure Mg and MgeSr alloys were used to evaluate the
antibacterial performance, also with CaSO4, HA, and b-TCP
as a comparison. A 316 L stainless steel was used as a posi-
tive control in the antibacterial evaluation. The experi-
mental samples were placed in one well of a 24-multiwell
culture plate. There was 0.8 mL of bacterial suspensions
with concentration of (5e10)  105 cfu/mL, Staphylococcus
aureus ATCC25923 was dropped into the wells containing
different samples and were then incubated at 37C for
6 hours, 12 hours, and 24 hours, respectively. Then the
cocultured bacterial suspensions were diluted to
(5e10)  102 CFU/mL. There was 0.05 mL of this diluted
bacterial suspension that was added onto the nutrition agar
plates and spread evenly, which were incubated again at
37C for another 24 hours to count bacterial colonies [19].
Figure 1 X-ray diffraction patterns of the as-extruded mag-
nesiumestrontium alloys.
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Statistical analysis was conducted with SP13.0 (IBM, Armonk,
NY, USA). Differences among groups were analysed using
multianalysis of variance followed by Tukey test. A p value
0.05was set as indicating statistically significant difference.
Results
Microstructure and mechanical properties
The XRD analysis of MgeSr alloys indicated the constitution
of a-Mg matrix and second phase present as Mg17Sr2. TheFigure 2 Optical micrographs of as-cast (A1eD1) and as-extruded
magnesiumestrontium (MgeSr) alloys. (A) Mge0.25Sr. (B) Mge1.0Sdiffraction intensities of the Mg17Sr2 phase increased with
increasing Sr content (Fig. 1). The microstructures of MgeSr
alloys in Fig. 2 also showed the typical metallographic
microstructural feature of a-Mg grains with the precipitating
second phase. For as-cast MgeSr alloys, because of the low
solid solubility of Sr in binary alloy, the needle-like second
phase formed in the interior of the grains, also with some
scattered particles. With the increase in Sr content, more
Mg17Sr2 precipitated along the grain boundaries, also leading
to the finer grain size. After extrusion, the second phase was
broken and evenly distributed at the grain boundary;
meanwhile, the extrusion stripes were found along the di-
rection of processing. The varying size of second-phase
particles was observed in the longitudinal section. These
brittle phases were usually detrimental to tensile proper-
ties, which could be the origins of crack propagation.
The UTS, YS, and elongation of MgeSr alloys are shown in
Fig. 3. Mge0.25Sr showed the highest elongation (13%), but
the lowest YS (195 MPa). The YS was increased with the
addition of Sr up to 2.5 wt% because of the second-phase
strengthening; meanwhile, the tensile strength showed no
significant influence in the range of 0.25e2.5 wt%. By
contrast, elongation was continuously descending when the
amounts of Sr were further increased. The results indicated
that the Mgexwt% Sr (x Z 1.0 and x Z 1.5) possessed the
optimized combination of strength and ductility.
Bending properties were also important especially for
bone graft substitutes. Fig. 4 shows the effect of Sr on the
bending properties of Mg. The highest bending strength is
obtained for Mge0.25Sr, whereas the bending strength
decreased with the addition of Sr. The bending properties
of the as-extruded MgeSr alloys studied here showed
the opposite compositional dependence as the tensile
properties. It was reported that the bending properties(A2eD2 in the longitudinal section, A3eD3 in the cross section)
r. (C) Mge1.5Sr. (D) Mge2.5Sr.
Figure 3 Mechanical properties of the as-extruded magne-
siumestrontium(MgeSr) alloys. The strengthofMgeSr alloyswas
enhanced with an increase in Sr contents; meanwhile, ductility
had deteriorated. It was found that optimized mechanical
property could be obtained with Sr contents of 1.0 and 1.5.
A
B
Figure 5 The compressive strength of (A) magnesiumestron-
tium (MgeSr) alloys and (B) pure Mg after different immersion
times. It was found that with an increase in Sr contents up to
1.5 wt% the compressive strength was improved, and then
decreased for Mge2.5Sr. The compressive properties of pure Mg
and MgeSr alloys did not show significant loss during immersion
periods of 28 days (p > 0.05).
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amounts of Mg17Sr2 phase were produced with the addition
of Sr, and the tensile strength was improved because of the
precipitation strengthening. However, particles with un-
even size distributed on the matrix could influence inter-
face adhesion, which was attributed to the deterioration of
bending strength.
The compressive strength, which was proved to be the
most important performance of bone void filler materials,
were evaluated on pure Mg and MgeSr alloys also with im-
mersion for 7 days, 14 days, and 28 days. The compressive
properties of MgeSr alloys were improved with the addition
of Sr up to 1.5 wt%, and then decreased for Mge2.5Sr
(Fig. 5). The compressive strength of MgeSr alloys was
higher than that of pure Mg except Mge0.25Sr. Moreover, it
was found that the compressive strength was slightly
increased with immersion time, but without significant
statistical difference (p > 0.05). Because of the relativelyFigure 4 The variation of bending strength generated by
three-point bending test of as-extruded magnesiumestrontium
(MgeSr; 0.25e2.5wt%) alloys at room temperature. The bending
strength showed significant decrease with addition of Sr.short in vitro immersion, no obvious mechanical loss was
observed and the minor volume change caused by the uni-
form corrosion mainly contributed to the variation of
compressive measurements.
Electrochemical corrosion behaviour
Potentiodynamic polarization was applied to evaluate the
corrosion resistance of the MgeSr alloys compared with
pure Mg. Fig. 6 shows the polarization curves of the
experimental samples immersed in Hank solution. The
corrosion potential (Ecorr), the current density (Icorr),
polarized resistant (Rp), and corrosion rate (CR) calculated
according to the ASTM-G102-89 standard [21] are listed in
Table 2. The polarization curves indicated that both the
anodic and cathodic reactions rates were much reduced for
the MgeSr alloys in comparison with pure Mg, as evidenced
by a large shift of the curve toward lower densities for
similar potentials. There was no significant difference of
Potentiodynamic polarization curve change for MgeSr
Figure 6 Potentiodynamic polarization curves of as-
extruded magnesiumestrontium (MgeSr) alloys and pure Mg.
144 C. Liu et al.alloys in the range of 0.25e1.5 wt%. However, the corrosion
potential of Mge2.5Sr showed an apparent shift to the
anodic direction, indicating better corrosion resistance. It
can be found that the anodic current density of MgeSr al-
loys increased slowly from the free corrosion potential
(Ecorr) to approximately 1.55 V, and then the corrosion
current density increased quickly. This result indicates that
the MgeSr alloys can retard the Mg from the corrosion when
the potential was more negative than 1.55 V. Then the
alloys underwent severe attack with increase of the anodic
potential. With the increase in the Sr contents, the free
corrosion current (Icorr) was significantly decreased from
3.03 mA/cm2 to 1.36 mA/cm2, which was also approximately
two to five times lower than that for the pure Mg (6.78 mA/
cm2). The increase in corrosion resistance (Rp) for the
MgeSr alloys was approximately two to three times higher
than that for pure Mg. In conclusion, the degradation of
MgeSr alloys could be controlled with the addition of Sr,
which was reflected by the decreased corrosion rate with
an increase in Sr contents as shown in Table 2.
In vitro immersion evaluation
The pH curves of the pure Mg and the Mgexwt% Sr
(xZ 0.25, xZ 1.0, xZ 1.5, xZ 2.5) alloys during 25 days’
immersion are shown in Fig. 7. The pH value of pure Mg
increased to 9.8 at the initial stage and fluctuated in the
range of approximately 9.8e10. With immersion time, theTable 2 The Tafel fitting parameters obtained from potentiody
Pure Mg Mge0.25Sr
Ecorr (V) 1.79  0.02 1.81  0.02
Icorr (mAcm
2) 6.78  1.47 3.03  0.73
Rp (KUcm
2) 11.23  3.19 23.91  0.68
ba (mV) 331.7  56.1 343.7  79.8
bc (mV) 346.3  52.2 275.2  56.4
CR (mm/y) 0.17  0.01 0.07  0.02
CR Z corrosion rate; Ecorr Z corrosion potential; Icorr Z current denspH value slightly decreased and approached 9.6 at Day 25.
The pH of MgeSr alloys decreased later to about 8.7 and
remained stable during the immersion periods. The pH
value was slightly decreased with increase in Sr content,
except Mge2.5Sr alloy. Overall, pH value of the MgeSr al-
loys was definitely lower compared to the pure Mg.
After addition of chromic acid solution, corrosion
assessment by weight loss after immersion of 28 days was
analysed and illustrated graphically as CR in Fig. 8. The
in vitro CR of MgeSr alloys displayed an increase with
increasing amounts of Sr contents up to 1.0 wt%, whereas
that value decreased when the addition of Sr was further
increased after 28 days’ immersion. It was found that with Sr
incorporation the second phase precipitated on the grain
boundary, which could lead to deterioration of the corrosion
of the Mg matrix in the form of galvanic corrosion. On the
contrary, the second phases distributed in the shape of
continuous net in the matrix could form a compact oxidation
film, which inhibited further corrosion. Thus, the increasing
amounts of refined Mg17Sr2 dispersed in the a-Mg matrix
might act as corrosion barriers, which could improve corro-
sion resistance. The CR illustrated the similar degradation
trend with electrochemical test, supporting the suggestion
that MgeSr alloys with increase of Sr allowed a controlled
degradation compared with pure Mg in Hank solution.
Biocompatibility
Cytotoxicity
In vitro cytotoxicity of the as-extruded MgeSr alloys was
assessed by measuring the viability of the preosteoblasts
MC3T3-E1 after 24 hours of culture in the extraction me-
diums according to ISO10993-5, also with as-extruded pure
Mg as the control. The result is shown in Fig. 9. It can be seen
that no cytotoxicity of all types of Mgexwt% Sr was found
and the cell viabilities of Mgexwt% Sr (x Z 1.0, x Z 1.5,
xZ 2.5) were well above 100% and higher than that of pure
Mg, indicating that Sr addition significantly improved the
cell proliferation and displayed excellent biocompatibility.
The extract of the as-extruded Mge1.5Sr alloy led to the
highest cell viability and showed Grade 0 cytotoxicity as well
as Mge1.0Sr and Mge2.5Sr. Cytotoxicity of Grade 1 was
shown by Mge0.25Sr according to ISO10993-5, suggesting
good cytocompatibility and acceptable biosafety for cellular
applications.
Cell adhesion
Fig. 10 depicts the fluorescence images of murine calvarial
preosteoblasts (MC3T3-E1) adhesion on as-extrudednamic polarization curves.
Mge1.0Sr Mge1.5Sr Mge2.5Sr
1.79  0.001 1.77  0.02 1.68  0.04
2.93  0.27 2.93  0.58 1.36  0.41
24.23  2.88 28.67  3.85 32.05  4.41
373.2  105.5 392.8  50.9 199.3  3 3.8
294.3  44.1 423.5  112.8 192.0  33.3
0.07  0.01 0.07  0.01 0.03  0.01
ity; Mg Z magnesium; Rp Z polarized resistant; Sr Z strontium.
Figure 7 pH monitoring of pure magnesium (Mg) and
Mgestrontium (Sr) alloys during in vitro immersion periods.
MgeSr alloys exhibited lower pH value than pure Mg. In addi-
tion, the pH value was slightly decreased with increases in Sr
content, except for the Mge2.5Sr alloy.
Figure 9 MC3T3-E1 cell viability after incubation of 24 h in
the extracts of as-extruded magnesium (Mg)exwt% Sr alloy
(x Z 0.25, x Z 1.0, x Z 1.5, x Z 2.5) and pure Mg. The Mg-
based metals exhibited acceptable cytotoxicity for medical
device, and the Mgestrontium (Sr) alloys improved the cell
proliferation with increase in Sr contents compared with pure
Mg (*p < 0.05).
Investigation of a magnesium-based bone graft substitute 145Mgexwt% Sr alloys (x Z 0.25, 1.0, 1.5, 2.5) and pure Mg
stained with DAPI after 30 minutes, 60 minutes, and
120 minutes of incubation. Only small amounts of the
MC3T3-E1cells (small round blue dots in Fig. 10A) adhered
on the surfaces of MgeSr alloys and pure Mg after 30 mi-
nutes of incubation. Along with the extension of the incu-
bation time, the cell number on the surfaces of different
samples was obviously increasing. In addition, a growing
number of punctiform corrosion products were produced on
the surface of different samples with the processing of
culture and also stained with DAPI (irregular-shaped big
blue dots in Fig. 10). The stained products were larger than
the cells and affected the growth of the cells on the surface
of the samples. At the time point of 120-min incubation,
the more cells and fewer products were obviously found onFigure 8 Corrosion rate of pure magnesium (Mg) and
Mgestrontium (Sr) alloys calculated by mass loss after immer-
sion of 28 days. The corrosion rate increased with addition of Sr
up to 1.0 wt%, then decreased with further increase in Sr
contents (*p < 0.05).the MgeSr alloys in comparison with that of pure Mg. It can
be concluded that cells adhered to and spread better on
the surfaces of MgeSr alloys than that on the surface of
pure Mg.
Antibacterial performance
The value of the colony-forming unit (CFU) in culture
(Fig. 11) showed that pure Mg and Mge1.5Sr alloys inhibited
colony growth of S. aureus whereas cultures containing
316L continued a stable growth. By 24 hours, the cultures
containing Mg-based metal had decreased bacterial growth
to nearly zero colonies because of high alkaline pH values.
However, the groups of CaSO4, HA, and TCP as the com-
parison showed an increase in bacterial colonization, indi-
cating a high risk of infection after implantation.
Discussion
In recent years the Mg-based metals have attracted great
attention as potential biodegradable implants, such as
vascular stents and bone fixation. In this work, the feasi-
bility of Mg-based metals used as bone defect filler had
been evaluated from the aspect of mechanical properties,
degradation behaviour, and biocompatibility according to
the generalized request for bone graft substitutes accord-
ing to the literature [7]. As an important element of med-
ical device or material development, commercially
available control material for comparison is essential [22].
Thus, we used commercial CaSO4 (Osteoset), HA (Pro-
Osteon), and b-TCP (ChronOS) as the controls for compar-
ison as well.
The repair of large bony defects caused by trauma or
disease remains a major problem in trauma and orthopae-
dic surgery. The past decade has seen increasing amounts
of bone substitute materials becoming available for use in
trauma and orthopaedic surgery. Synthetic substitutes
are mineral structures similar to human bone with
Figure 10 The fluorescence images of murine calvarial preosteoblasts (MC3T3-E1) adhesion on as-extruded magnesium (Mg)exSr
alloy (xZ 0.25, xZ 1.0, xZ 1.5, xZ 2.5) and pure Mg stained with 40, 60-diamidino-2-phenylindole (DAPI) after 30 min (A1eE1),
60 min (A2eE2), and 120 min (A3eE3) of incubation. (A) Mge0.25Sr. (B) Mge1.0Sr. (C) Mge1.5Sr. (D) Mge2.5Sr. (E) Pure Mg.
146 C. Liu et al.osteoconductive properties. They include calcium phos-
phate ceramics such as HA, and absorbable TCP. CaSO4, or
plaster of Paris, has been used as a bone loss filler since the
late 1980s [23]. It has resorbable osteoconductive proper-
ties because of its three-dimensional structural framework.
Additionally, bioactive glass was also defined as hard, solid
materials consisting of sodium oxide, calcium oxide, silicon
dioxide, and phosphorus in various proportions, available as
nonresorbable grafts [24]. It displays mainly osteo-
conductive properties and has few osteoinductive proper-
ties [7].
The structural, biological, and biomechanical properties
of bone grafts are critical to their clinical success. From aFigure 11 The colony-forming unit/mL of Staphylococcus
aureus suspension after incubation with different samples.
*p < 0.05 compared with pure Mg; **p < 0.05 compared with
Mge1.5Sr. Mg Z magnesium; SR Z strontium.biological point of view, a ‘‘biological chamber’’ must be
created that is a biological reactor in which all the ele-
ments (cells, growth factors, and scaffolds) needed for
bone regeneration are present [25]. Almost all bone graft
substitutes possess only osteoconductive properties but no
osteoinductive activity. The common methods to improve
the osteoinductivity were incorporation of demineralized
bone matrix, bone morphogenetic protein, and growth
factors into composites. As for Mg-based metal, it is known
to stimulate the growth of bone cells and accelerate the
bone-tissue healing process [26]. Mg is also one of the
essential elements for human metabolism [27]; when used
in vivo the degradation of Mg could be nontoxic and elim-
inated in the urine [28]. Additionally, Sr is also a bone-
seeking element, of which 98% in the human body can be
found in the skeleton [29]. Orally supplemented strontium
is reported to improve vertebral bone density and stimulate
bone formation [30]. In our work, the pure Mg and MgeSr
alloys showed better cytocompatibility and improved
MC3T3 cells adhesion and proliferation. Gu et al. [12] also
proved a stimulatory effect of Sr on osteoblastic cell pro-
liferation and differentiation. Additionally, the inhibitory
effect of Sr on osteoclasts proliferation will be helpful in
preventing bone resorption [31]. Therefore, MgeSr alloys
are of osteopromotion and osteoconduction for potential
use in bone graft substitutes.
In addition to biological properties, bone substitutes
should offer optimal biomechanical strength, especially in
the femur and the tibia, which are under high weight-
bearing loads. An ideal bone substitute material should
offer the same biomechanical strength as the bone being
replaced. Human cortical bone has a compressive strength
of 130e290 MPa and a tensile strength of 90e190 MPa,
whereas the compressive strength of cancellous bone is in
the range 2e38 MPa [32].The comparison of compressive
Figure 12 The comparison of compressive strength for nat-
ural bone, commercial bone-grafting products, and
magnesium-based metals.
Investigation of a magnesium-based bone graft substitute 147strength for natural bone, commercial bone grafting prod-
ucts and Mg-based metals is shown in Fig. 12 [37,38]. It is
clearly seen that none of the commercial bone substitutes,
except bioactive glass, can offer a biomechanical strength
similar to that of cortical bone. Calcium phosphate grafts
(HA and b-TCP) possess compressive strengths comparable
to those of spongy bone. CaSO4 provides only minimal
structural support. Bioactive glass has a compressive
strength of 91e197 MPa but its tensile strength does not
reach values comparable to that of cortical bone [33].
Thus, these bone substitutes appear to be unsuitable for
filling cortical bone defects without additional support.
Comparatively, the Mg-based metals have excellent me-
chanical properties close to those of natural bone, as shown
in Fig. 12. With an increase in Sr contents, the compressive
strength was increased because of precipitation strength,
and was also significantly higher than those commercial
bone-grafting materials. Meanwhile, Mg-based metals
exhibited negligible loss of mechanical strength even when
immersed in Hank solution for 28 days. Therefore, the
mechanical performance of pure Mg and MgeSr alloys could
satisfy the demand for regeneration of load-bearing
segmental bone defects.
Bioreabsorption of bone substitutes seems to be related
to their properties. HA ceramics are fairly inert, resorption
of b-TCP products is mediated by osteoclastic activity, and
resorption time varies between 6 months and 24 months
[34]. The resorption of bioactive glass is variable and de-
pends upon the relative amounts of the different constit-
uents. Among those bone grafts, CaSO4 has a rapid
resorption rate and is fully dissolved within 6e12 weeks
[35].The rapid corrosion rate of the Mg-based metals is the
major drawback and limits their clinical application. The
resorption may be completed prior to sufficient new bone
formation. The common approaches to this challenge are
alloying and surface modification [36]. MgeSr alloys showed
better corrosion resistance with the addition of Sr
compared with pure Mg. Moreover, the controlled degra-
dation rate in the range of 0.05e0.07 mm/year was
significantly lower than with CaSO4, and faster than with HA
and TCP, indicating the feasibility of bone void filler.
The excellent combination of mechanical properties,
biodegradable behaviour, and biocompatibility for Mg-
based metals, especially MgeSr alloys reported in thecurrent study, suggested its potential as bone graft sub-
stitutes. Our in vitro study laid a good foundation for
clinical indication-based or a disease-oriented in vivo
model to investigate their role as bone defect filler in bone
regeneration, especially in conditions with bone infections.
In conclusion, the Mg-based metals including pure Mg
and Mgexwt% Sr (x Z 0.25, x Z 1.0, x Z 1.5, x Z 2.5)
alloys were studied as potential use of bone graft sub-
stitutes. The mechanical properties, degradation behav-
iour, and biocompatibility were evaluated and also
compared with commercial bone grafts such as CaSO4, HA,
and b-TCP. The MgeSr alloys showed better tensile and
compressive strength with an increase in Sr contents
because of precipitation strength. The advantages of
biomechanical performance over commercial bone sub-
stitutes (HA, b-TCP, CaSO4, and bioglass) suggested possible
use for regeneration of load-bearing segmental bone de-
fects. The CR was controlled in the low range of
0.05e0.07 mm/year with the addition of Sr. Moreover,
MgeSr alloys also showed excellent biocompatibility and
antibacterial performance, which could be helpful for bone
regeneration after bone void filling and avoidance of
infection. Our innovation presented in this work supported
in vivo clinical indication-based assessment of biodegrad-
able Mg-based metals that could be potential candidates as
bone graft substitutes for future orthopaedic applications.Conflicts of interest
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